| Scientific Name |
Emtricitabine, Elvitegravir , Cobicistat ,Tenofovir, Alafenamide
|
|---|---|
| Brand Name |
Genvoya
|
| Risk |
Increased risk of treatment failure and increased risk of mother-to-child transmission of HIV infection due to lower exposure of elvitegravir and cobicistat during the second and third trimesters of pregnancy.
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|